Ambu CEO on stream of launches: "Won't be easy, but we're building an ecosystem"

In the next three years, Ambu expects to launch four times as many products as during its prior strategy period, and the CEO sees clear advantages to scaling the firm at this speed. At the same time, the company needs to succeed with the ecosystem of products which the CEO plans to establish at hospitals worldwide.

Ambu CEO Juan Jose Gonzalez | Photo: Ambu/PR

BY ULRICH QUISTGAARD, TRANSLATED BY NIELSINE NIELSEN

Published: 15.02.21 at 11:36

Ambu is pushing the pedal to the metal to establish itself on the single-use endoscope market.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

Access all locked articles
Receive our daily newsletters
Access our app

Start a free company trial today

Ellab slapped with customs fine over US imports

Danish medtech producer Ellab broke US customs rules and is now paying the price.

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

CEO gets "taste of own medicine" by participating in vaccine trial

Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.

FDA approves Covid-19 jabs as boosters for infants

The US Food and Drug Administration has approved the use of Moderna and Pfizer/Biontech’s coronavirus vaccines as boosters for children as young as six months old.

EU Commission proposes staggered transition to new medtech requirements after industry warnings

After criticism for a lack of clarity on the regulation for medtech devices from doctors and industry players, the EU Commission has proposed an extension of the transition period.

MedWatch

Ambu CEO on stream of launches: "Won't be easy, but we're building an ecosystem"

Read the whole article

Get full access for you and your coworkers.

More from MedWatch

Ellab slapped with customs fine over US imports

China approves Y-mabs drug

CEO gets "taste of own medicine" by participating in vaccine trial

FDA approves Covid-19 jabs as boosters for infants

EU Commission proposes staggered transition to new medtech requirements after industry warnings

Further reading

Related articles

Latest news

Job